Inter-laboratory evaluation of the bioluminescent Salmonella reverse mutation assay using 10 model chemicals.

We have developed the bioluminescent Salmonella reverse mutation assay as a tool for detecting mutagenicity applicable for high-throughput screening of new chemicals. In this study, we report the inter-laboratory evaluation of the assay using 10 model chemicals in five independent laboratories located in the USA (Groton, CT; Cambridge, MA and La Jolla, CA), Europe (Sandwich, Kent, UK) and Asia (Nagoya, Japan). The studies were performed in blinded fashion in all sites except for Groton and Cambridge laboratories. The chemicals were tested in at least three independent experiments using strains TA98-lux and TA100-lux in the presence and absence of metabolic activation. The results were statistically evaluated and compared to published results. Seven of the 10 compounds were positive in either TA98-lux and/or TA100-lux in the presence or absence of metabolic activation. The positive compound set included: nitrofurazone, 3-3'-dimethoxybenzidine, benzo[a]pyrene, 1,4-benzoquinone dioxime, 2-amino-5-nitrophenol, 2-bromo-4,6-dinitroaniline and busulfan. The remaining three compounds, namely, anthracene, crystal violet and benzyl chloride were negative in both Salmonella strains. Final results for individual compounds yielded 100% agreement among the laboratories and published data. Detailed comparison of all 40 individual test conditions yielded 93% (37 of 40) agreement among participating laboratories. We conclude that the bioluminescent Salmonella reverse mutation assay is a robust, accurate and economical higher throughput assay applicable for the mutagenicity screening of chemicals.

[1]  H. Vainio,et al.  Mutascreen, an automated bacterial mutagenicity assay. , 1985, Mutation research.

[2]  E. Zeiger,et al.  Salmonella mutagenicity test results for 250 chemicals. , 1983, Environmental mutagenesis.

[3]  B. Ames,et al.  Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria for detection. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[4]  T. Brooks.  The use of a streamlined bacterial mutagenicity assay, the MINISCREEN. , 1995, Mutagenesis.

[5]  B. Margolin,et al.  Prediction of rodent carcinogenicity utilizing a battery of in vitro and in vivo genotoxicity tests , 1999, Environmental and molecular mutagenesis.

[6]  D. G. Gosslee,et al.  Ethylene oxide dose and dose-rate effects in the mouse dominant-lethal test. , 1986, Environmental mutagenesis.

[7]  E Zeiger,et al.  Identification of rodent carcinogens and noncarcinogens using genetic toxicity tests: premises, promises, and performance. , 1998, Regulatory toxicology and pharmacology : RTP.

[8]  G. Lucier,et al.  Cytogenetic and chemical detection of human exposure to polyhalogenated aromatic hydrocarbons , 1988, Environmental and molecular mutagenesis.

[9]  B. Ames,et al.  Detection and classification of mutagens: a set of base-specific Salmonella tester strains. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[10]  E. Zeiger,et al.  Salmonella mutagenicity tests: IV. Results from the testing of 300 chemicals , 1988, Environmental and molecular mutagenesis.

[11]  T Sofuni,et al.  ICH-harmonised guidances on genotoxicity testing of pharmaceuticals: evolution, reasoning and impact. , 1999, Mutation research.

[12]  E. Zeiger,et al.  Salmonella mutagenicity tests: III. Results from the testing of 255 chemicals. , 1987, Environmental mutagenesis.

[13]  Jiri Aubrecht,et al.  Bioluminescent Salmonella reverse mutation assay: a screen for detecting mutagenicity with high throughput attributes. , 2007, Mutagenesis.

[14]  Spiral Salmonella assay: Validation against the standard pour‐plate assay , 1996, Environmental and molecular mutagenesis.

[15]  L. Claxton,et al.  Development and validation of the spiral Salmonella assay: an automated approach to bacterial mutagenicity testing. , 1989, Mutation research.

[16]  R. Snyder,et al.  Comparison of the results of a modified miniscreen and the standard bacterial reverse mutation assays , 2000, Environmental and molecular mutagenesis.

[17]  E. Zeiger,et al.  Salmonella mutagenicity tests: II. Results from the testing of 270 chemicals. , 1986, Environmental mutagenesis.

[18]  E. Zeiger,et al.  Salmonella mutagenicity tests: V. Results from the testing of 311 chemicals , 1992, Environmental and molecular mutagenesis.

[19]  B. Burlinson,et al.  Use of the Miniscreen assay to screen novel compounds for bacterial mutagenicity in the pharmaceutical industry. , 1996, Mutagenesis.

[20]  J W Green,et al.  A review of the genotoxicity of marketed pharmaceuticals. , 2001, Mutation research.